Article
The role of miRNA -31-3p and miR-31-5p in the anti-EGFR treatment efficacy of wild-type K-RAS metastatic colorectal cancer. Is it really the next best thing in miRNAs?
Journal of B.U.ON. : official journal of the Balkan Union of Oncology - 1 Jan 2000
Sur Daniel, Cainap Calin, Burz Claudia, Havasi Andrei, Chis Irina Camelia, Vlad Catalin, Milosevic Vladan, Balacescu Ovidiu, Irimie Alexandru
Abstract excerpt
Colorectal cancer (CRC) is one of the most common cancers worldwide with a high incidence and mortality. Although many treatment options are available in stage IV disease, the clinical outcome is still minimal. The primary treatment problem in metastatic colorectal cancer (mCRC) is early liver metastases that occur in more than 50% of patients. First-line treatment in metastatic colorectal cancer (mCRC) is a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.